Diabetes Drugs Unexpectedly Raise Levels of Gut Microbe-Linked Heart Risk Marker TMAO
A pooled analysis of two placebo-controlled crossover trials shows that the SGLT-2 inhibitors empagliflozin and dapagliflozin modestly but significantly raise ...
Tag: empagliflozin
SGLT2 Inhibitors Found to Repair Heart Metabolism Through Coenzyme A Pathway
New evidence shows SGLT2 inhibitors protect the failing heart by directly activating PANK1 to restore coenzyme A biosynthesis and myocardial ...
Diabetes Drug Protects Against Deadly Aneurysms by Reshaping the Gut Microbiome
New research shows the diabetes drug empagliflozin protects against experimental abdominal aortic aneurysm by reshaping the gut microbiome and strengthening ...
Popular Diabetes Drugs Show No Effect on Thyroid Hormone or Inflammation Markers
A retrospective study of 330 patients with type 2 diabetes found that long-term use of SGLT-2 inhibitors empagliflozin and dapagliflozin ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!